» Articles » PMID: 28314894

Development of Anticancer Agents Targeting the Hedgehog Signaling

Overview
Publisher Springer
Specialty Biology
Date 2017 Mar 19
PMID 28314894
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Hedgehog signaling is an evolutionarily conserved pathway which is essential in embryonic and postnatal development as well as adult organ homeostasis. Abnormal regulation of Hedgehog signaling is implicated in many diseases including cancer. Consequently, substantial efforts have made in the past to develop potential therapeutic agents that specifically target the Hedgehog signaling for cancer treatment. Here, we review the therapeutic agents for inhibition of the Hedgehog signaling and their clinical advances in cancer treatment.

Citing Articles

The role of Hedgehog and Notch signaling pathway in cancer.

Xia R, Xu M, Yang J, Ma X Mol Biomed. 2022; 3(1):44.

PMID: 36517618 PMC: 9751255. DOI: 10.1186/s43556-022-00099-8.


Predictive Design and Analysis of Drug Transport by Multiscale Computational Models Under Uncertainty.

Akalin A, Dedekarginoglu B, Choi S, Han B, Ozcelikkale A Pharm Res. 2022; 40(2):501-523.

PMID: 35650448 PMC: 9712595. DOI: 10.1007/s11095-022-03298-8.


Gemcitabine-induced Gli-dependent activation of hedgehog pathway resists to the treatment of urothelial carcinoma cells.

Chang Y, Tam H, Lu M, Huang H PLoS One. 2021; 16(7):e0254011.

PMID: 34237099 PMC: 8266077. DOI: 10.1371/journal.pone.0254011.


A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth.

Lospinoso Severini L, Quaglio D, Basili I, Ghirga F, Bufalieri F, Caimano M Cancers (Basel). 2019; 11(10).

PMID: 31601026 PMC: 6826940. DOI: 10.3390/cancers11101518.


Primary Cilia as Signaling Hubs in Health and Disease.

Nishimura Y, Kasahara K, Shiromizu T, Watanabe M, Inagaki M Adv Sci (Weinh). 2019; 6(1):1801138.

PMID: 30643718 PMC: 6325590. DOI: 10.1002/advs.201801138.


References
1.
Pullamsetti S, Banat G, Schmall A, Szibor M, Pomagruk D, Hanze J . Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF. Oncogene. 2012; 32(9):1121-34. DOI: 10.1038/onc.2012.136. View

2.
Yauch R, Gould S, Scales S, Tang T, Tian H, Ahn C . A paracrine requirement for hedgehog signalling in cancer. Nature. 2008; 455(7211):406-10. DOI: 10.1038/nature07275. View

3.
List A, Beran M, DiPersio J, Slack J, Vey N, Rosenfeld C . Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes. Leukemia. 2003; 17(8):1499-507. DOI: 10.1038/sj.leu.2403021. View

4.
Fukushima N, Minami Y, Kakiuchi S, Kuwatsuka Y, Hayakawa F, Jamieson C . Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells. Cancer Sci. 2016; 107(10):1422-1429. PMC: 5084664. DOI: 10.1111/cas.13019. View

5.
Ge X, Milenkovic L, Suyama K, Hartl T, Purzner T, Winans A . Phosphodiesterase 4D acts downstream of Neuropilin to control Hedgehog signal transduction and the growth of medulloblastoma. Elife. 2015; 4. PMC: 4569902. DOI: 10.7554/eLife.07068. View